Abstract
The efficacies of ketoconazole and two new imidazole preparations, Bay N7133 and Bay L9139, were compared in a rat model of experimental candida vaginitis. With a dosage regimen of 10 mg/kg by gavage for 5 days, the cure rate for ketoconazole was 96% as compared with rates of 23 and 29% for Bay N7133 and Bay L9139, respectively (P less than 0.001). Follow-up vaginal cultures at 30 days revealed a relapse in only 1 of 27 rats treated with ketoconazole. Our subsequent experiment in which ketoconazole regimens of 10 mg/kg were compared with Bay N7133 and Bay L9139 regimens of 25 mg/kg demonstrated cure rates of 100, 15, and 82% for the respective agents.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference7 articles.
1. Treatment of vaginal candidiasis with ketoconazole, a new orally active antimycotic;Blsschop M. P. J. M.;Eur. J. Obstet. Gynecol. Reprod. Biol.,1979
2. Ketoconazole, a new antifungal agent in vaginal candidiasis;Creatsas G.;Curr. Ther. Res. Clin. Exp.,1980
3. Ketoconazole in vulvovaginal candidiasis;Fregoso-Duenas F.;Rev. Infect. Dis.,1980
4. Evaluation of vaginal antifungal formulation in vivo;McRipley R. J.;Postgrad. Med. J.,1979
5. Odds F. C. 1979. Candida and candidiasis p. 55. University Park Press Baltimore.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献